XERIS BIOPHARMA HOLDINGS, INC. (XERS) Gross margin
XERIS BIOPHARMA HOLDINGS, INC. (XERS) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to XERSSource: SEC XBRL filings · For reference only · Not investment advice
More XERS financial trends
XERS RevenueXERS Net incomeXERS Net marginXERS Gross profitXERS Operating incomeXERS Operating marginXERS Operating cash flowXERS Free cash flowXERS Capital expendituresXERS Return on equityXERS Stock buybacksXERS Dividends paidXERS Total assetsXERS Total liabilitiesXERS Shareholders’ equityXERS overview →